Remaining alive after amniotic fluid embolism: A case report

Amniyon sıvı embolisi (AFE) gebelikte nadir görülen fakat çok ciddi seyirli bir komplikasyondur. İnsidansı 1:8000 ile 1:80000 arasında değişmektedir. Mortalite oranı %61-86 dır. Neonatal sağ kalım % 40-70 dir.Vakamız sağlıklı 36 yaşında multigravid eylemin indüksiyonu için yatırılmış 39 haftalık gebeydi. Eylemin aktif fazında AFE gelişti. Başlangıç semptomu akut ve ciddi hipotansiyon, takiben periferal dolaşım kollapsı ,siyanoz ve akut solunum yetmezliğidir. Hasta acil olarak sezeryana alındı. Nörolojik olarak fetus sağlam olarak çıkarıldı sonrasında annede ciddi hemoraji ve DIC gelişti. Ciddi koagülopatiye rağmen hasta bir hafta içinde hastaneden taburcu edilebildi. Amniyon sıvı embolisi yönetimi çok zor olan nadir görülen fakat çok ciidi seyirli bir komplikasyondur. Bu sebeple AFE yönetimi deneyimli ve nitelikli hekimlerin bulunduğu multidisipliner hastanelerde yapılmalıdır.

Amniyon sıvı embolisi sonrası sağ kalım : Olgu sunumu

Amnion fluid embolism (AFE) is a rare but catastrophic complication of pregnancy. Its incidence varies from 1:8000 to 1:80.000 and the mortality rate is about 61- 86%. Neonatal survival reaches 40-70% Our case was a healthy, 36 year old multigravida at 39 weeks gestation hospitalized for induction of labor, which developed AFE in the active phase of labor. Initial symptom was acute and severe hypotension, followed by collapse of peripheral circulation, cyanosis and acute respiratory failure. The patient underwent an urgent cesarean section with the survival of neurologically intact fetus but complicated with severe hemorrhage and DIC.Despite of severe coagulopathy, the mother was discharged from the hospital at the end of one week. Amniotic fluid embolism is a very complicated problem, difficult to manage. Complete management of AFE requires qualified, experienced and multidisciplinary physicians.

___

  • 1. Meyer JR (1926) Embolia pulmonar amnio caseosa. J Bras Med 2:301–303
  • 2.Clark SL, Hankins GD, Dudley DA et al. Amniotic fluid embolism: Analysis of the national registry. Am J Obstet Gynecol 1995; 172: 1159–1167.
  • 3. Kramer MS, Rouleau J, Baskett TF, et al. Amniotic-fluid embolism and medical induction of labour: a retrospective, population-based cohort study. Lancet 2006;368(9545):1444–8.
  • 4. Gilbert WM, Danielson B. Amniotic fluid embolism: decreased mortality in a populationbased study. Obstet Gynecol 1999;93(6):973–7.
  • 5. Morgan M (1979) Amniotic Xuid embolism. Anaesthesia 34:20–32
  • 6. Tuffnell DJ. United Kingdom amniotic fluid embolism register. BJOG 2005;112(12):1625–9.
  • 7. Lau G, Chui PP. Amniotic fluid embolism: a review of 10 fatal cases. Singapore Med J 1994; 35:180–3.
  • 8. Resnik R, Swartz WH, Plummer MH, et al. Amniotic fluid embolism with survival. Obstet Gynecol 1976;47:295–8.
  • 9. Karetzky M, Ramirez M (1998) Acute respiratory failure in pregnancy. An analysis of 19 cases. Medicine 77:41–49
  • 10. Roche WD Jr, Norris HJ (1974) Detection and significance of maternal pulmonary amniotic embolism. Obstet Gynecol 43:729–731
  • 11. BensonMD, Kobayashi H, Silver RK, et al. Immunologic studies in presumed amniotic fluid embolism. Obstet Gynecol 2001;97(4):510–4.
  • 12.Aurangzeb I, George L & Raoof S. Amniotic fluid embolism. Crit Care Clin 2004; 20: 643–650.
  • 13. Locksmith GJ. Amniotic fluid embolism. Obstet Gynecol Clin North Am 1999; 26: 435–444.
  • 14. Kane SK. Historical perspective of amniotic fluid embolism. Int Anesthesiol Clin 2005; 43: 99–108.
  • 15. Lim Y, Loo CC, Chia V, et al. Recombinant factor VIIa after amniotic fluid embolism and disseminated intravascular coagulopathy. Int J Obstet Gynecol 2004;87:178–9.